decreased body length_Fgfr3<tm1Llm>/Fgfr3<+>

http://metadb.riken.jp/0001258I129S2SvPasFgfr3tm1LlmFgfr3Fgfr3Fgfr3tm1Llm

decreased body length_Fgfr3<tm1Llm>/Fgfr3<+>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• fibroblast growth factor receptor 3
  http://metadb.riken.jp/db/mgi_rdf/MGI:95524

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Fgfr3<tm1Llm>/Fgfr3<+>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Fgfr3<+>|Fgfr3<tm1Llm>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S2/SvPas

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased body length
  http://purl.obolibrary.org/obo/MP_0001258

文献

http://purl.org/net/cito/citesAsAuthority

• Florence. Lorget, et.al., Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia., American journal of human genetics, 2012, 91
  http://rdf.ncbi.nlm.nih.gov/pubmed/23200862